Director Ali-Jackson Kamil sold $72,925 worth of shares (2,500 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 12,625 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

RIGL· Rigel Pharmaceuticals Inc.

Health Care

Original source

Director Ali-Jackson Kamil sold $72,925 worth of shares (2,500 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 12,625 units (SEC Form 4) | Quantisnow